[Facial infantile aggressive fibromatosis: a frequent localization of an exceptional tumor!]

Ann Chir Plast Esthet. 2012 Jun;57(3):304-7. doi: 10.1016/j.anplas.2009.12.005. Epub 2010 Jun 18.
[Article in French]

Abstract

Introduction: Although fibromatosis is considered as benign tumor, it can have significant morbidity, particularly when it occurs in the head and neck. Their propensity for infiltrative local growth with encroachment on vital structures and their tendency to recur make fibromatoses of the head and neck extremely challenging lesions.

Case report: We report the case of a 10-year-old boy with desmoid fibromatosis of the upper lip. For this patient, the medical treatment has been decided to avoid a mutilating surgery. He had a good result with chemotherapy using methotrexate and vinblastine.

Discussion: According to the literature, surgery is the most common treatment of fibromatosis in the head and neck region. However, particularly in children, alternative modes of therapy must be considered because of the high recurrence rate and to avoid mutilating operations. Chemotherapy using methotrexate and vinblastine may be a reasonable choice.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Biopsy
  • Child
  • Drug Administration Schedule
  • Fibromatosis, Aggressive / diagnosis*
  • Fibromatosis, Aggressive / drug therapy*
  • Fibromatosis, Aggressive / pathology
  • Follow-Up Studies
  • Humans
  • Lip / pathology
  • Lip Neoplasms / diagnosis*
  • Lip Neoplasms / drug therapy*
  • Lip Neoplasms / pathology
  • Magnetic Resonance Imaging
  • Male
  • Methotrexate / administration & dosage
  • S100 Proteins / analysis
  • Vinblastine / administration & dosage

Substances

  • Biomarkers, Tumor
  • S100 Proteins
  • Vinblastine
  • Methotrexate